-
1
-
-
20444418706
-
MAPK kinase kinases (MKKKs) as a target class for small-molecule inhibition to modulate signaling networks and gene expression
-
DOI 10.1016/j.cbpa.2005.04.004, PII S1367593105000578, Combinatorial Chemistry
-
Johnson GL, Dohlman HG, Graves LM 2005 MAPK kinase kinases (MKKKs) as a target class for small-molecule inhibition to modulate signaling networks and gene expression. Curr Opin Chem Biol 9:325-331 (Pubitemid 40804557)
-
(2005)
Current Opinion in Chemical Biology
, vol.9
, Issue.3
, pp. 325-331
-
-
Johnson, G.L.1
Dohlman, H.G.2
Graves, L.M.3
-
2
-
-
79953904634
-
Inhibition of the Ras/Raf/MEK/ERK and RET kinase pathways with the combination of the multikinase inhibitor sorafenib and the farnesyltransferase inhibitor tipifarnib in medullary and differentiated thyroid malignancies
-
Hong DS, Cabanillas ME, Wheler J, Naing A, Tsimberidou AM, Ye L, Waguespack SG, Hernandez M, El Naggar AK, El Naggar AK, Bidyasar S, Wright J, Sherman SI, Kurzrock R, Busaidy NL 2011 Inhibition of the Ras/Raf/MEK/ERK and RET kinase pathways with the combination of the multikinase inhibitor sorafenib and the farnesyltransferase inhibitor tipifarnib in medullary and differentiated thyroid malignancies. J Clin Endocrinol Metab 96:997-1005
-
(2011)
J Clin Endocrinol Metab
, vol.96
, pp. 997-1005
-
-
Hong, D.S.1
Cabanillas, M.E.2
Wheler, J.3
Naing, A.4
Tsimberidou, A.M.5
Ye, L.6
Waguespack, S.G.7
Hernandez, M.8
El Naggar, A.K.9
El Naggar, A.K.10
Bidyasar, S.11
Wright, J.12
Sherman, S.I.13
Kurzrock, R.14
Busaidy, N.L.15
-
3
-
-
79952261716
-
GSK1120212 (JTP-74057) is an inhibitor of MEK activity and activation with favorable pharmacokinetic properties for sustained in vivo pathway inhibition
-
Gilmartin AG, Bleam MR, Groy A, Moss KG, Minthorn EA, Kulkarni SG, Rominger CM, Erskine S, Fisher KE, Yang J, Zappacosta F, Annan R, Sutton D, Laquerre SG 2011 GSK1120212 (JTP-74057) is an inhibitor of MEK activity and activation with favorable pharmacokinetic properties for sustained in vivo pathway inhibition. Clin Cancer Res 17:989-1000
-
(2011)
Clin Cancer Res
, vol.17
, pp. 989-1000
-
-
Gilmartin, A.G.1
Bleam, M.R.2
Groy, A.3
Moss, K.G.4
Minthorn, E.A.5
Kulkarni, S.G.6
Rominger, C.M.7
Erskine, S.8
Fisher, K.E.9
Yang, J.10
Zappacosta, F.11
Annan, R.12
Sutton, D.13
Laquerre, S.G.14
-
4
-
-
77949766280
-
Phase I pharmacokinetic and pharmacodynamic study of the oral MAPK/ERK kinase inhibitor PD-0325901 in patients with advanced cancers
-
LoRusso PM, Krishnamurthi SS, Rinehart JJ, Nabell LM, Malburg L, Chapman PB, DePrimo SE, Bentivegna S, Wilner KD, Tan W, Ricart AD 2010 Phase I pharmacokinetic and pharmacodynamic study of the oral MAPK/ERK kinase inhibitor PD-0325901 in patients with advanced cancers. Clin Cancer Res 16:1924-1937
-
(2010)
Clin Cancer Res
, vol.16
, pp. 1924-1937
-
-
LoRusso, P.M.1
Krishnamurthi, S.S.2
Rinehart, J.J.3
Nabell, L.M.4
Malburg, L.5
Chapman, P.B.6
DePrimo, S.E.7
Bentivegna, S.8
Wilner, K.D.9
Tan, W.10
Ricart, A.D.11
-
5
-
-
70349273655
-
Response and resistance to MEK inhibition in leukaemias initiated by hyperactive Ras
-
Lauchle JO, Kim D, Le DT, Akagi K, Crone M, Krisman K, Warner K, Bonifas JM, Li Q, Coakley KM, Diaz-Flores E, Gorman M, Przybranowski S, Tran M, Kogan SC, Roose JP, Copeland NG, Jenkins NA, Parada L, Wolff L, Sebolt-Leopold J, Shannon K 2009 Response and resistance to MEK inhibition in leukaemias initiated by hyperactive Ras. Nature 461:411-414
-
(2009)
Nature
, vol.461
, pp. 411-414
-
-
Lauchle, J.O.1
Kim, D.2
Le, D.T.3
Akagi, K.4
Crone, M.5
Krisman, K.6
Warner, K.7
Bonifas, J.M.8
Li, Q.9
Coakley, K.M.10
Diaz-Flores, E.11
Gorman, M.12
Przybranowski, S.13
Tran, M.14
Kogan, S.C.15
Roose, J.P.16
Copeland, N.G.17
Jenkins, N.A.18
Parada, L.19
Wolff, L.20
Sebolt-Leopold, J.21
Shannon, K.22
more..
-
6
-
-
79953252390
-
A MEK inhibitor abrogates myeloproliferative disease in Kras mutant mice
-
Lyubynska N, Gorman MF, Lauchle JO, Hong WX, Akutagawa JK, Shannon K, Braun BS 2011 A MEK inhibitor abrogates myeloproliferative disease in Kras mutant mice. Sci Transl Med 3:76ra27
-
(2011)
Sci Transl Med
, vol.3
-
-
Lyubynska, N.1
Gorman, M.F.2
Lauchle, J.O.3
Hong, W.X.4
Akutagawa, J.K.5
Shannon, K.6
Braun, B.S.7
-
7
-
-
34547803312
-
Rickets due to hereditary abnormalities of vitamin D synthesis or action
-
Glorieux FH, Pettifor JM, Juppner H, eds. San Diego: Academic Press
-
Portale AA, Miller WL 2003 Rickets due to hereditary abnormalities of vitamin D synthesis or action. In: Glorieux FH, Pettifor JM, Juppner H, eds. Pediatric bone. San Diego: Academic Press; 583-598
-
(2003)
Pediatric Bone
, pp. 583-598
-
-
Portale, A.A.1
Miller, W.L.2
-
8
-
-
0942279588
-
Renal Phosphate Wasting Disorders: Clinical Features and Pathogenesis
-
DOI 10.1053/j.semnephrol.2003.08.016
-
Brame LA, White KE, Econs MJ 2004 Renal phosphate wasting disorders: clinical features and pathogenesis. Semin Nephrol 24:39-47 (Pubitemid 38141843)
-
(2004)
Seminars in Nephrology
, vol.24
, Issue.1
, pp. 39-47
-
-
Brame, L.A.1
White, K.E.2
Econs, M.J.3
-
9
-
-
77957107138
-
Altered renal FGF23-mediated activity involving MAPK and Wnt: Effects of the Hyp mutation
-
Farrow EG, Summers LJ, Schiavi SC, McCormick JA, Ellison DH, White KE 2010 Altered renal FGF23-mediated activity involving MAPK and Wnt: effects of the Hyp mutation. J Endocrinol 207:67-75
-
(2010)
J Endocrinol
, vol.207
, pp. 67-75
-
-
Farrow, E.G.1
Summers, L.J.2
Schiavi, S.C.3
McCormick, J.A.4
Ellison, D.H.5
White, K.E.6
-
11
-
-
0032893855
-
X-linked hypophosphataemia: A homologous disorder in humans and mice
-
DOI 10.1093/ndt/14.2.333
-
Tenenhouse HS 1999 X-linked hypophosphataemia: a homologous disorder in humans and mice. Nephrol Dial Transplant 14:333-341 (Pubitemid 29062787)
-
(1999)
Nephrology Dialysis Transplantation
, vol.14
, Issue.2
, pp. 333-341
-
-
Tenenhouse, H.S.1
-
12
-
-
0002701258
-
Mendelian hypophosphatemias
-
Scriver CR, Beaudet AL, Sly WS, Vale D, eds. New York: McGraw Hill
-
Tenenhouse HS, Econs MJ 2001 Mendelian hypophosphatemias. In: Scriver CR, Beaudet AL, Sly WS, Vale D, eds. The metabolic and molecular basis of inherited disease. New York: McGraw Hill; 5039-5068
-
(2001)
The Metabolic and Molecular Basis of Inherited Disease
, pp. 5039-5068
-
-
Tenenhouse, H.S.1
Econs, M.J.2
-
13
-
-
8244251430
-
Distribution of mutations in the PEX gene in families with X-linked hypophosphataemic rickets (HYP)
-
DOI 10.1093/hmg/6.4.539
-
Rowe PS, Oudet CL, Francis F, Sinding C, Pannetier S, Econs MJ, Strom TM, Meitinger T, Garabedian M, David A, Macher MA, Quesitaux E, Popowska E, Pronicka E, Read AP, Mokrzycki A, Glorieux FH, Drezner MK, Hanauer A, Lenrach H, Goulding JN, O'Riordan JL 1997 Distribution of mutations in the PEX gene in families with X-linked hypophosphataemic rickets (HYP). Hum Mol Genet 6:539-549 (Pubitemid 27142102)
-
(1997)
Human Molecular Genetics
, vol.6
, Issue.4
, pp. 539-549
-
-
Rowe, P.S.N.1
Oudet, C.L.2
Francis, F.3
Sinding, C.4
Pannetier, S.5
Econs, M.J.6
Strom, T.M.7
Meitinger, T.8
Garabedian, M.9
David, A.10
Macher, M.-A.11
Questiaux, E.12
Popowska, E.13
Pronicka, E.14
Read, A.P.15
Mokrzycki, A.16
Glorieux, F.H.17
Drezner, M.K.18
Hanauer, A.19
Lehrach, H.20
Goulding, J.N.21
O'Riordan, J.L.H.22
more..
-
14
-
-
20244368616
-
Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia
-
DOI 10.1056/NEJMoa020881
-
Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, Yamamoto T, Hampson G, Koshiyama H, Ljunggren O, Oba K, Yang IM, Miyauchi A, Econs MJ, Lavigne J, Jüppner H 2003 Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 348:1656-1663 (Pubitemid 36459471)
-
(2003)
New England Journal of Medicine
, vol.348
, Issue.17
, pp. 1656-1663
-
-
Jonsson, K.B.1
Zahradnik, R.2
Larsson, T.3
White, K.E.4
Sugimoto, T.5
Imanishi, Y.6
Yamamoto, T.7
Hampson, G.8
Koshiyama, H.9
Ljunggren, O.10
Oba, K.11
Yang, I.M.12
Miyauchi, A.13
Econs, M.J.14
Lavigne, J.15
Juppner, H.16
-
15
-
-
33745850756
-
Pathogenic role of Fgf23 in Hyp mice
-
DOI 10.1152/ajpendo.00008.2006
-
Liu S, Zhou J, Tang W, Jiang X, Rowe DW, Quarles LD 2006 Pathogenic role of Fgf23 in Hyp mice. Am J Physiol Endocrinol Metab 291:E38-E49 (Pubitemid 44035308)
-
(2006)
American Journal of Physiology - Endocrinology and Metabolism
, vol.291
, Issue.1
-
-
Liu, S.1
Zhou, J.2
Tang, W.3
Jiang, X.4
Rowe, D.W.5
Quarles, L.D.6
-
16
-
-
33646367420
-
Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D
-
DOI 10.1681/ASN.2005111185
-
Liu S, Tang W, Zhou J, Stubbs JR, Luo Q, Pi M, Quarles LD 2006 Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. J Am Soc Nephrol 17:1305-1315 (Pubitemid 43673410)
-
(2006)
Journal of the American Society of Nephrology
, vol.17
, Issue.5
, pp. 1305-1315
-
-
Liu, S.1
Tang, W.2
Zhou, J.3
Stubbs, J.R.4
Luo, Q.5
Pi, M.6
Quarles, L.D.7
-
17
-
-
0141525564
-
Serum FGF23 Levels in Normal and Disordered Phosphorus Homeostasis
-
DOI 10.1359/jbmr.2003.18.7.1227
-
Weber TJ, Liu S, Indridason OS, Quarles LD 2003 Serum FGF23 levels in normal and disordered phosphorus homeostasis. J Bone Miner Res 18:1227-1234 (Pubitemid 37294915)
-
(2003)
Journal of Bone and Mineral Research
, vol.18
, Issue.7
, pp. 1227-1234
-
-
Weber, T.J.1
Liu, S.2
Indridason, O.S.3
Quarles, L.D.4
-
18
-
-
0017032590
-
Hypophosphatemia: mouse model for human familial hypophosphatemic (vitamin D resistant) rickets
-
DOI 10.1073/pnas.73.12.4667
-
Eicher EM, Southard JL, Scriver CR, Glorieux FH 1976 Hypophosphatemia: mouse model for human familial hypophosphatemic (vitamin D-resistant) rickets. Proc Natl Acad Sci USA 73:4667-4671 (Pubitemid 8013582)
-
(1976)
Proceedings of the National Academy of Sciences of the United States of America
, vol.73
, Issue.12
, pp. 4667-4671
-
-
Eicher, E.M.1
Southard, J.L.2
Scriver, C.R.3
Glorieux, F.H.4
-
19
-
-
0018961064
-
Abnormal vitamin D metabolism in the X-linked hypophosphatemic mouse
-
Meyer Jr RA, Gray RW, Meyer MH 1980 Abnormal vitamin D metabolism in the X-linked hypophosphatemic mouse. Endocrinology 107:1577-1581 (Pubitemid 10029756)
-
(1980)
Endocrinology
, vol.107
, Issue.5
, pp. 1577-1581
-
-
Meyer Jr., R.A.1
Cray, R.W.2
Meyer, M.H.3
-
20
-
-
0019434180
-
Serum 1,25-dihydroxyvitamin D concentration in hypophosphatemic vitamin D-resistant rickets
-
Delvin EE, Glorieux FH 1981 Serum 1,25-dihydroxyvitamin D concentrations in hypophosphatemic vitamin D-resistant rickets. Calcif Tissue Int 33:173-175 (Pubitemid 11100010)
-
(1981)
Calcified Tissue International
, vol.33
, Issue.2
, pp. 173-175
-
-
Delvin, E.E.1
Glorieux, F.H.2
-
21
-
-
9644303231
-
Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice
-
DOI 10.1016/j.matbio.2004.09.007, PII S0945053X04001155
-
Sitara D, Razzaque MS, Hesse M, Yoganathan S, Taguchi T, Erben RG, Jüppner H, Lanske B 2004 Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice. Matrix Biol 23:421-432 (Pubitemid 39576657)
-
(2004)
Matrix Biology
, vol.23
, Issue.7
, pp. 421-432
-
-
Sitara, D.1
Razzaque, M.S.2
Hesse, M.3
Yoganathan, S.4
Taguchi, T.5
Erben, R.G.6
Juppner, H.7
Lanske, B.8
-
22
-
-
33847095086
-
Pharmacodynamic and toxicokinetic evaluation of the novel MEK inhibitor, PD0325901, in the rat following oral and intravenous administration
-
DOI 10.1007/s00280-006-0323-5
-
Brown AP, Carlson TC, Loi CM, Graziano MJ 2007 Pharmacodynamic and toxicokinetic evaluation of the novel MEK inhibitor, PD0325901, in the rat following oral and intravenous administration. Cancer Chemother Pharmacol 59:671-679 (Pubitemid 46295133)
-
(2007)
Cancer Chemotherapy and Pharmacology
, vol.59
, Issue.5
, pp. 671-679
-
-
Brown, A.P.1
Carlson, T.C.G.2
Loi, C.-M.3
Graziano, M.J.4
-
23
-
-
36549040859
-
The selectivity of protein kinase inhibitors: A further update
-
Bain J, Plater L, Elliott M, Shpiro N, Hastie CJ, McLauchlan H, Klevernic I, Arthur JS, Alessi DR, Cohen P 2007 The selectivity of protein kinase inhibitors: a further update. Biochem J 408:297-315
-
(2007)
Biochem J
, vol.408
, pp. 297-315
-
-
Bain, J.1
Plater, L.2
Elliott, M.3
Shpiro, N.4
Hastie, C.J.5
McLauchlan, H.6
Klevernic, I.7
Arthur, J.S.8
Alessi, D.R.9
Cohen, P.10
-
24
-
-
0036527429
-
Protein kinases - The major drug targets of the twenty-first century?
-
Cohen P 2002 Protein kinases - the major drug targets of the twenty-first century? Nat Rev Drug Discov 1:309-315 (Pubitemid 37361447)
-
(2002)
Nature Reviews Drug Discovery
, vol.1
, Issue.4
, pp. 309-315
-
-
Cohen, P.1
-
25
-
-
36049037977
-
Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1α-hydroxylase expression in vitro
-
DOI 10.1152/ajprenal.00463.2006
-
Perwad F, Zhang MY, Tenenhouse HS, Portale AA 2007 Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1α-hydroxylase expression in vitro. Am J Physiol Renal Physiol 293:F1577-F1583 (Pubitemid 350085994)
-
(2007)
American Journal of Physiology - Renal Physiology
, vol.293
, Issue.5
-
-
Perwad, F.1
Zhang, M.Y.H.2
Tenenhouse, H.S.3
Portale, A.A.4
-
26
-
-
0036155775
-
Dietary phosphorus transcriptionally regulates 25-hydroxyvitamin D-1α-hydroxylase gene expression in the proximal renal tubule
-
DOI 10.1210/en.143.2.587
-
Zhang MY, Wang X, Wang JT, Compagnone NA, Mellon SH, Olson JL, Tenenhouse HS, Miller WL, Portale AA 2002 Dietary phosphorus transcriptionally regulates 25-hydroxyvitamin D-1α-hydroxylase gene expression in the proximal renal tubule. Endocrinology 143:587-595 (Pubitemid 34107213)
-
(2002)
Endocrinology
, vol.143
, Issue.2
, pp. 587-595
-
-
Zhang, M.Y.H.1
Wang, X.2
Wang, J.T.3
Compagnone, N.A.4
Mellon, S.H.5
Olson, J.L.6
Tenenhouse, H.S.7
Miller, W.L.8
Portale, A.A.9
-
27
-
-
34250745769
-
Isolation of renal proximal tubular brush-border membranes
-
DOI 10.1038/nprot.2007.156, PII NPROT.2007.156
-
Biber J, Stieger B, Stange G, Murer H 2007 Isolation of renal proximal tubular brush-border membranes. Nat Protoc 2:1356-1359 (Pubitemid 46952317)
-
(2007)
Nature Protocols
, vol.2
, Issue.6
, pp. 1356-1359
-
-
Biber, J.1
Stieger, B.2
Stange, G.3
Murer, H.4
-
28
-
-
55749104922
-
The extracellular calcium-sensing receptor (CaSR) is a critical modulator of skeletal development
-
Chang W, Tu C, Chen TH, Bikle D, Shoback D 2008 The extracellular calcium-sensing receptor (CaSR) is a critical modulator of skeletal development. Sci Signal 1:ra1
-
(2008)
Sci Signal
, vol.1
-
-
Chang, W.1
Tu, C.2
Chen, T.H.3
Bikle, D.4
Shoback, D.5
-
29
-
-
12344262661
-
Skeletal overexpression of gremlin impairs bone formation and causes osteopenia
-
DOI 10.1210/en.2004-0766
-
Gazzerro E, Pereira RC, Jorgetti V, Olson S, Economides AN, Canalis E 2005 Skeletal overexpression of gremlin impairs bone formation and causes osteopenia. Endocrinology 146:655-665 (Pubitemid 40129821)
-
(2005)
Endocrinology
, vol.146
, Issue.2
, pp. 655-665
-
-
Gazzerro, E.1
Pereira, R.C.2
Jorgetti, V.3
Olson, S.4
Economides, A.N.5
Canalis, E.6
-
30
-
-
0023488581
-
Bone histomorphometry: Standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee
-
Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595-610
-
(1987)
J Bone Miner Res
, vol.2
, pp. 595-610
-
-
Parfitt, A.M.1
Drezner, M.K.2
Glorieux, F.H.3
Kanis, J.A.4
Malluche, H.5
Meunier, P.J.6
Ott, S.M.7
Recker, R.R.8
-
31
-
-
0032482367
-
Stress-induced immediate-early gene, egr-1, involves activation of p38/JNK1
-
Lim CP, Jain N, Cao X 1998 Stress-induced immediate-early gene, egr-1, involves activation of p38/JNK1. Oncogene 16:2915-2926 (Pubitemid 28383276)
-
(1998)
Oncogene
, vol.16
, Issue.22
, pp. 2915-2926
-
-
Lim, C.P.1
Jain, N.2
Cao, X.3
-
32
-
-
0035469890
-
Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor α expression by inducing Elk-1 phosphorylation and Egr-1 expression
-
Guha M, O'Connell MA, Pawlinski R, Hollis A, McGovern P, Yan SF, Stern D, Mackman N 2001 Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor α expression by inducing Elk-1 phosphorylation and Egr-1 expression. Blood 98:1429-1439
-
(2001)
Blood
, vol.98
, pp. 1429-1439
-
-
Guha, M.1
O'Connell, M.A.2
Pawlinski, R.3
Hollis, A.4
McGovern, P.5
Yan, S.F.6
Stern, D.7
Mackman, N.8
-
33
-
-
3042634460
-
Transgenic mice expressing fibroblast growth factor 23 under the control of the α1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis
-
DOI 10.1210/en.2003-1768
-
Larsson T, Marsell R, Schipani E, Ohlsson C, Ljunggren O, Tenenhouse HS, Jüppner H, Jonsson KB 2004 Transgenic mice expressing fibroblast growth factor 23 under the control of the α1(I) collagen promoter exhibit growth retardation, osteomalacia and disturbed phosphate homeostasis. Endocrinology 145:3087-3094 (Pubitemid 38829975)
-
(2004)
Endocrinology
, vol.145
, Issue.7
, pp. 3087-3094
-
-
Larsson, T.1
Marsell, R.2
Schipani, E.3
Ohlsson, C.4
Ljunggren, O.5
Tenenhouse, H.S.6
Juppner, H.7
Jonsson, K.B.8
-
34
-
-
9144248333
-
FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa
-
DOI 10.1016/j.bbrc.2003.12.102
-
Shimada T, Urakawa I, Yamazaki Y, Hasegawa H, Hino R, Yoneya T, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T 2004 FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa. Biochem Biophys Res Commun 314:409-414 (Pubitemid 38084732)
-
(2004)
Biochemical and Biophysical Research Communications
, vol.314
, Issue.2
, pp. 409-414
-
-
Shimada, T.1
Urakawa, I.2
Yamazaki, Y.3
Hasegawa, H.4
Hino, R.5
Yoneya, T.6
Takeuchi, Y.7
Fujita, T.8
Fukumoto, S.9
Yamashita, T.10
-
35
-
-
0026736322
-
Effect of dietary phosphate deprivation and supplementation of recipient mice on bone formation by transplanted cells from normal and X-linked hypophosphatemic mice
-
Ecarot B, Glorieux FH, Desbarats M, Travers R, Labelle L 1992 Effect of dietary phosphate deprivation and supplementation of recipient mice on bone formation by transplanted cells from normal and X-linked hypophosphatemic mice. J Bone Miner Res 7:523-530
-
(1992)
J Bone Miner Res
, vol.7
, pp. 523-530
-
-
Ecarot, B.1
Glorieux, F.H.2
Desbarats, M.3
Travers, R.4
Labelle, L.5
-
36
-
-
0020187970
-
Healing of bone lesions with 1,25-dihydroxyvitamin D3 in the young X-linked hypophosphatemic male mouse
-
Marie PJ, Travers R, Glorieux FH 1982 Healing of bone lesions with 1,25-dihydroxyvitamin D3 in the young X-linked hypophosphatemic male mouse. Endocrinology 111:904-911
-
(1982)
Endocrinology
, vol.111
, pp. 904-911
-
-
Marie, P.J.1
Travers, R.2
Glorieux, F.H.3
-
37
-
-
0020028750
-
Bone response to phosphate and vitamin D metabolites in the hypophosphatemic male mouse
-
Marie PJ, Travers R, Glorieux FH 1982 Bone response to phosphate and vitamin D metabolites in the hypophosphatemic male mouse. Calcif Tissue Int 34:158-164 (Pubitemid 12128643)
-
(1982)
Calcified Tissue International
, vol.34
, Issue.2
, pp. 158-164
-
-
Marie, P.J.1
Travers, R.2
Glorieux, F.H.3
-
38
-
-
2142746439
-
FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis
-
DOI 10.1359/JBMR.0301264
-
Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukumoto S, Yamashita T 2004 FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19:429-435 (Pubitemid 38787398)
-
(2004)
Journal of Bone and Mineral Research
, vol.19
, Issue.3
, pp. 429-435
-
-
Shimada, T.1
Hasegawa, H.2
Yamazaki, Y.3
Muto, T.4
Hino, R.5
Takeuchi, Y.6
Fujita, T.7
Nakahara, K.8
Fukumoto, S.9
Yamashita, T.10
-
39
-
-
14344279878
-
Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia
-
DOI 10.1073/pnas.101545198
-
Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T 2001 Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA 98:6500-6505 (Pubitemid 32488266)
-
(2001)
Proceedings of the National Academy of Sciences of the United States of America
, vol.98
, Issue.11
, pp. 6500-6505
-
-
Shimada, T.1
Mizutani, S.2
Muto, T.3
Yoneya, T.4
Hino, R.5
Takeda, S.6
Takeuchi, Y.7
Fujita, T.8
Fukumoto, S.9
Yamashita, T.10
-
41
-
-
0037008747
-
Fibroblast growth factor (FGF)-23 inhibits renal phosphate reabsorption by activation of the mitogen-activated protein kinase pathway
-
DOI 10.1074/jbc.M202527200
-
Yamashita T, Konishi M, Miyake A, Inui K, Itoh N 2002 Fibroblast growth factor (FGF)-23 inhibits renal phosphate reabsorption by activation of the mitogen-activated protein kinase pathway. J Biol Chem 277:28265-28270 (Pubitemid 34966781)
-
(2002)
Journal of Biological Chemistry
, vol.277
, Issue.31
, pp. 28265-28270
-
-
Yamashita, T.1
Konishi, M.2
Miyake, A.3
Inui, K.-I.4
Itoh, N.5
-
42
-
-
49749145970
-
FGF-23-Klotho signaling stimulates proliferation and prevents vitamin D-induced apoptosis
-
Medici D, Razzaque MS, DeLuca S, Rector TL, Hou B, Kang K, Goetz R, Mohammadi M, Kuro-O M, Olsen BR, Lanske B 2008 FGF-23-Klotho signaling stimulates proliferation and prevents vitamin D-induced apoptosis. J Cell Biol 182:459-465
-
(2008)
J Cell Biol
, vol.182
, pp. 459-465
-
-
Medici, D.1
Razzaque, M.S.2
DeLuca, S.3
Rector, T.L.4
Hou, B.5
Kang, K.6
Goetz, R.7
Mohammadi, M.8
Kuro-O, M.9
Olsen, B.R.10
Lanske, B.11
-
43
-
-
37149047561
-
Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice
-
DOI 10.1152/ajpendo.00396.2007
-
Liu S, Tang W, Zhou J, Vierthaler L, Quarles LD 2007 Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice. Am J Physiol Endocrinol Metab 293:E1636-E1644 (Pubitemid 350255114)
-
(2007)
American Journal of Physiology - Endocrinology and Metabolism
, vol.293
, Issue.6
-
-
Liu, S.1
Tang, W.2
Zhou, J.3
Vierthaler, L.4
Quarles, L.D.5
-
45
-
-
74949106383
-
Increased bone volume and correction of HYP mouse hypophosphatemia in the Klotho/HYP mouse
-
Brownstein CA, Zhang J, Stillman A, Ellis B, Troiano N, Adams DJ, Gundberg CM, Lifton RP, Carpenter TO 2010 Increased bone volume and correction of HYP mouse hypophosphatemia in the Klotho/HYP mouse. Endocrinology 151:492-501
-
(2010)
Endocrinology
, vol.151
, pp. 492-501
-
-
Brownstein, C.A.1
Zhang, J.2
Stillman, A.3
Ellis, B.4
Troiano, N.5
Adams, D.J.6
Gundberg, C.M.7
Lifton, R.P.8
Carpenter, T.O.9
-
46
-
-
0036479315
-
Overexpression of Phex in osteoblasts fails to rescue the Hyp mouse phenotype
-
DOI 10.1074/jbc.M107707200
-
Liu S, Guo R, Tu Q, Quarles LD 2002 Overexpression of Phex in osteoblasts fails to rescue the Hyp mouse phenotype. J Biol Chem 277:3686-3697 (Pubitemid 34953243)
-
(2002)
Journal of Biological Chemistry
, vol.277
, Issue.5
, pp. 3686-3697
-
-
Liu, S.1
Guo, R.2
Tu, Q.3
Darryl, Q.L.4
-
47
-
-
20844431717
-
Overexpression of human PHEX under the human β-actin promoter does not fully rescue the Hyp mouse phenotype
-
DOI 10.1359/JBMR.050212
-
Erben RG, Mayer D, Weber K, Jonsson K, Jüppner H, Lanske B 2005 Overexpression of human PHEX under the human β-actin promoter does not fully rescue the Hyp mouse phenotype. J Bone Miner Res 20:1149-1160 (Pubitemid 40863802)
-
(2005)
Journal of Bone and Mineral Research
, vol.20
, Issue.7
, pp. 1149-1160
-
-
Erben, R.G.1
Mayer, D.2
Weber, K.3
Jonsson, K.4
Juppner, H.5
Lanske, B.6
-
48
-
-
12244263475
-
Partial rescue of the Hyp phenotype by osteoblast-targeted PHEX (phosphate-regulating gene with homologies to endopeptidases on the X chromosome) expression
-
DOI 10.1210/me.2002-0113
-
Bai X, Miao D, Panda D, Grady S, McKee MD, Goltzman D, Karaplis AC 2002 Partial rescue of the Hyp phenotype by osteoblast-targeted PHEX (phosphate-regulating gene with homologies to endopeptidases on the X chromosome) expression. Mol Endocrinol 16:2913-2925 (Pubitemid 36020666)
-
(2002)
Molecular Endocrinology
, vol.16
, Issue.12
, pp. 2913-2925
-
-
Bai, X.1
Miao, D.2
Panda, D.3
Grady, S.4
McKee, M.D.5
Goltzman, D.6
Karaplis, A.C.7
-
49
-
-
59449106235
-
The PHEX transgene corrects mineralization defects in 9-month-old hypophosphatemic mice
-
Boskey A, Frank A, Fujimoto Y, Spevak L, Verdelis K, Ellis B, Troiano N, Philbrick W, Carpenter T 2009 The PHEX transgene corrects mineralization defects in 9-month-old hypophosphatemic mice. Calcif Tissue Int 84:126-137
-
(2009)
Calcif Tissue Int
, vol.84
, pp. 126-137
-
-
Boskey, A.1
Frank, A.2
Fujimoto, Y.3
Spevak, L.4
Verdelis, K.5
Ellis, B.6
Troiano, N.7
Philbrick, W.8
Carpenter, T.9
-
50
-
-
73949119246
-
Therapeutic effects of anti-FGF23 antibodies in hypophosphatemic rickets/osteomalacia
-
Aono Y, Yamazaki Y, Yasutake J, Kawata T, Hasegawa H, Urakawa I, Fujita T, Wada M, Yamashita T, Fukumoto S, Shimada T 2009 Therapeutic effects of anti-FGF23 antibodies in hypophosphatemic rickets/osteomalacia. J Bone Miner Res 24:1879-1888
-
(2009)
J Bone Miner Res
, vol.24
, pp. 1879-1888
-
-
Aono, Y.1
Yamazaki, Y.2
Yasutake, J.3
Kawata, T.4
Hasegawa, H.5
Urakawa, I.6
Fujita, T.7
Wada, M.8
Yamashita, T.9
Fukumoto, S.10
Shimada, T.11
-
51
-
-
80053211073
-
FGF receptors control vitamin D and phosphate homeostasis by mediating renal FGF-23 signaling and regulating FGF-23 expression in bone
-
Wöhrle S, Bonny O, Beluch N, Gaulis S, Stamm C, Scheibler M, Müller M, Kinzel B, Thuery A, Brueggen J, Hynes NE, Sellers WR, Hofmann F, Graus-Porta D 2011 FGF receptors control vitamin D and phosphate homeostasis by mediating renal FGF-23 signaling and regulating FGF-23 expression in bone. J Bone Miner Res 26:2486-2497
-
(2011)
J Bone Miner Res
, vol.26
, pp. 2486-2497
-
-
Wöhrle, S.1
Bonny, O.2
Beluch, N.3
Gaulis, S.4
Stamm, C.5
Scheibler, M.6
Müller, M.7
Kinzel, B.8
Thuery, A.9
Brueggen, J.10
Hynes, N.E.11
Sellers, W.R.12
Hofmann, F.13
Graus-Porta, D.14
|